Peter Hosein, MD

Associate Professor
University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center., United States

Presentation(s):

• 44: Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)

  Thursday, March 21, 2024
  2:22pm – 2:32pm ET